Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Hum Lact ; 37(1): 139-146, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32579054

ABSTRACT

BACKGROUND: Neonatal infections with Cronobacter sakazakii have recently been associated with the consumption of expressed human milk. STUDY AIMS: (1) To evaluate whether human milk has antimicrobial capacity against C. sakazakii and (2) to determine the stability of its capacity when it is subjected to various treatments. METHODS: The antimicrobial capacity of human milk against C. sakazakii was evaluated using an observational, cross-sectional, comparative design. Mature human milk samples (N = 29) were subjected to different treatments. After incubation at 37°C for 72 hr, samples were compared with fresh milk on the stability of their antimicrobial capacity. Two-way analysis of variance (ANOVA) was performed. RESULTS: In fresh milk, counts of C. sakazakii were reduced by 47.26% (SD = 6.74) compared to controls. In treated milk, reductions were: refrigeration at 4°C for 72 hr (M = 33.84, SD = 13.84), freezing at -20°C for 1, 2, and 3 months (M = 40.31, SD = 9.10; M = 35.96, SD = 9.39; M = 26.20, SD = 13.55, respectively), Holder pasteurization (M = 23.56, SD = 15.61), and human milk bank treatment with (M = 14.37, SD = 18.02) and without bovine fortifier (M = 3.70, SD = 23.83). There were significant differences (p < .05) between fresh and treated milk. CONCLUSIONS: Human milk has antimicrobial capacity against C. sakazakii. However, its capacity is negatively influenced by common preservation and hygienization methods. Milk should be stored refrigerated for a maximum of 72 hr or frozen for a short period of time.


Subject(s)
Cronobacter sakazakii , Animals , Anti-Bacterial Agents/pharmacology , Breast Feeding , Cattle , Cross-Sectional Studies , Female , Humans , Infant Formula , Milk, Human , Temperature
2.
J Food Sci Technol ; 52(8): 5250-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26243949

ABSTRACT

Fungi play a key role in dry-cured ham production because of their lipolytic and proteolytic activities. In the present study, 74 fungal strains from dry-cured Teruel hams and air chambers were tested for proteolytic and lipolytic activities, with a view to their possible use as starter cultures. Lipolytic activity of fungi was studied against lauric, palmitic, stearic and oleic acids, whereas proteolytic activity was studied against casein and myosin. Of the 74 fungal strains tested, most of them demonstrated lipolytic activity (94.59 %). Lipolytic activity against lauric and oleic acids was stronger than against palmitic and stearic acids. 39 strains (52.70 %) demonstrated proteolytic activity against casein and the 6 highest proteolytic strains were also tested for pork myosin proteolysis. Some strains belonging to Penicillium commune, Penicillium chrysogenum, Penicillium nalgiovense and Cladosporium cladosporioides were selected because of their significant proteolytic and lipolytic activities and could be suitable to use as starters in dry-cured ham.

3.
Article in English | MEDLINE | ID: mdl-24279369

ABSTRACT

The present study reports the natural mycobiota occurring in dry-cured hams, and in particular on the incidence of mycotoxin-producing fungi. A total of 338 fungal colonies were isolated from three stages of production, these being the post-salting, ripening and aging stages in two manufacturing plants. The results show that fungi were more frequently isolated from the aging stage and that the predominant filamentous fungal genus isolated was Penicillium. Seventy-four of the 338 fungal strains were selected for identification at the species level by using morphological criteria and internal transcribed spacers sequencing. Of the 74 fungal strains, 59 were Penicillium strains. Sixteen Penicillium species were identified, with P. commune (24 strains) and P. chrysogenum (13 strains) being the most abundant. The potential ability to produce cyclopiazonic acid (CPA) and ochratoxin A (OTA) was studied by isolating the culture followed by HPLC analysis of these mycotoxins in the culture extracts. The results indicated that 25 (33.7%) of the 74 fungal strains produced CPA. Worth noting is the high percentage of CPA-producing strains of P. commune (66.6%) of which some strains were highly toxigenic. P. polonicum strains were also highly toxigenic. With respect to OTA-producing fungi, a low percentage of fungal strains (9.5%) were able to produce OTA at moderate levels. OTA-producing fungi belonged to different Penicillium species including P. chrysogenum, P. commune, P. polonicum and P. verrucosum. These results indicate that there is a possible risk factor posed by CPA and OTA contamination of dry-cured hams.


Subject(s)
Food Microbiology , Meat/microbiology , Mycotoxins/biosynthesis , Penicillium/isolation & purification , Penicillium/metabolism , Animals , DNA, Fungal/genetics , DNA, Fungal/isolation & purification , Food Contamination/analysis , Food Preservation/methods , Fungi/genetics , Fungi/isolation & purification , Fungi/metabolism , Humans , Indoles/metabolism , Indoles/toxicity , Meat/toxicity , Microbiota , Mycotoxins/genetics , Mycotoxins/toxicity , Ochratoxins/biosynthesis , Ochratoxins/toxicity , Penicillium/genetics , Spain , Species Specificity , Sus scrofa
4.
Poult Sci ; 92(4): 975-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23472021

ABSTRACT

The study was carried out under field conditions in a commercial farm, and 1,440 as-hatched Ross-308 broilers were included. Broilers were randomly distributed into 24 experimental 4-m(2) pens (60 broilers/pen). Pens were randomized to the 3 treatment groups: a) tylvalosin 10 mg/kg of live BW during 2 d, b) positive control (tylosin during 2 d), and c) negative control (no treatment). The drugs were provided in the water supply. Mortality, individual BW, and feed intake were assessed. Clostridium presence was assessed in fecal and cecal samples, coccidian oocyst counts were assessed in fecal samples, and bacterial diversity was assessed in ileal content. Live BW at 42 d old was significantly better in the tylvalosin group than in tylosin and no-treatment groups, with tylvalosin-treated broilers reaching 80 to 100 g higher final live weight. Average daily gain results mirrored BW findings. The improvement of feed conversion rate with tylvalosin amounted to 0.13 and to 0.10 versus tylosin and no-treatment, respectively, with mortality being similar in all groups. Significantly reduced sulfite-reducing Clostridium and Clostridium perfringens counts in tylvalosin and tylosin groups versus the no-treatment group were observed in cecum content samples. In conclusion, according to the present study results, tylvalosin, at doses substantially lower than registered for poultry in Europe, has proven effective in controlling the colonization of the cecum by Clostridium ssp. in broilers, improving some productive performances.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Chickens/growth & development , Clostridium Infections/veterinary , Intestinal Diseases/veterinary , Poultry Diseases/prevention & control , Tylosin/analogs & derivatives , Animals , Bacteria/isolation & purification , Biodiversity , Body Weight , Cecum/microbiology , Chickens/physiology , Clostridium Infections/microbiology , Clostridium Infections/mortality , Clostridium Infections/prevention & control , Clostridium perfringens/isolation & purification , Coccidiosis/parasitology , Coccidiosis/veterinary , Colony Count, Microbial/veterinary , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , Dose-Response Relationship, Drug , Eating , Eimeria/isolation & purification , Feces/microbiology , Feces/parasitology , Feeding Behavior , Ileum/microbiology , Intestinal Diseases/microbiology , Intestinal Diseases/mortality , Intestinal Diseases/prevention & control , Parasite Egg Count/veterinary , Polymerase Chain Reaction/veterinary , Polymorphism, Restriction Fragment Length , Poultry Diseases/microbiology , Poultry Diseases/mortality , Poultry Diseases/parasitology , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/metabolism , Tylosin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...